Zenas BioPharma, Inc.
ZBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$156,988 | -$37,124 | -$119,282 |
| Dep. & Amort. | $137 | $113 | $78 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $10,821 | $3,495 | $737 |
| Change in WC | $25,431 | -$8,039 | $7,967 |
| Other Non-Cash | $925 | $11,026 | $44,848 |
| Operating Cash Flow | -$119,674 | -$30,529 | -$65,652 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$131 | -$17 | -$198 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$36,421 | $0 | $0 |
| Inv. Sales/Matur. | $6,000 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$2,000 |
| Investing Cash Flow | -$30,552 | -$17 | -$2,198 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $20,000 | $0 |
| Stock Issued | $240,636 | $116 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $172,322 | $0 | $59,391 |
| Financing Cash Flow | $412,958 | $20,116 | $59,391 |
| Forex Effect | $157 | $78 | -$41 |
| Net Chg. in Cash | $262,889 | -$10,352 | -$8,500 |
| Supplemental Information | – | – | – |
| Beg. Cash | $56,943 | $67,295 | $75,795 |
| End Cash | $319,832 | $56,943 | $67,295 |
| Free Cash Flow | -$119,805 | -$30,546 | -$67,850 |